PCV13: Effective Against First-Episode CAP in Older Adults

Slideshow

The 13-valent pneumococcal conjugate vaccine reduced nearly by half vaccine-type community acquired pneumonia in adults aged 65 years and older.

Recent Videos
Tezepelumab Significantly Reduced Exacerbations in Patients with Severe Asthma, Respiratory Comorbidities
Interview with Kelly Moore, MD, MPH, president, chief executive officer, Immunization Action Coalition
Related Content
Moderna COVID-19 Vaccine mNEXSPIKE Approved Under New Eligibility Guidelines

Moderna COVID-19 Vaccine mNEXSPIKE FDA-Approved Under New Eligibility Guidelines

Grace Halsey
June 2nd 2025
Article

Moderna's mRNA-1283 vaccine gains FDA approval for high-risk groups, following a significant shift in COVID-19 vaccination guidelines by federal health agencies.

Respiratory Tripledemic 2022-23: An Expert Recap

Respiratory Tripledemic 2022-23: An Expert Recap

Sydney Jennings
April 6th 2023
Podcast

William Schaffner, MD, medical director of the NFID, provides an expert recap of the 2022-2023 respiratory virus season for primary care clinicians.

Telehealth Reduces Antibiotic Use for Pediatric ARTIs in Primary Care: Daily Dose / image credit: ©New Africa/AdobeStock

Telehealth Reduces Antibiotic Use for Pediatric ARTIs in Primary Care: Daily Dose

Sydney Jennings
May 28th 2025
Article

Your daily dose of the clinical news you may have missed.

NAVIGATOR: Tezepelumab Reduces Asthma Exacerbations by More than Half

NAVIGATOR: Tezepelumab Reduces Asthma Exacerbations by More than Half

Sydney Jennings
May 20th 2022
Podcast

In our latest podcast episode, Njira Lugogo, MD, discusses NAVIGATOR data she presented at ATS 2022 that showed clinical responses to treatment with tezepelumab.

Telehealth in Pediatric Primary Care Linked to Lower Antibiotic Prescribing for Respiratory Infections

Telehealth in Pediatric Primary Care Linked to Lower Antibiotic Prescribing for Respiratory Infections

Sydney Jennings
April 29th 2025
Article

Telehealth visits in pediatric primary care were linked to lower antibiotic prescribing rates for respiratory infections compared with in-person visits.

Direct Mail to Older Adults at Risk for Pneumococcal Disease Improves Vaccination Rates / image credit ©Kateryna_Kon/stock.adobe.com

Direct Mail to Older Adults at Risk for Pneumococcal Disease Improves Vaccination Rates

Grace Halsey
April 2nd 2025
Article

A mail campaign targeting adults with chronic conditions as well as their GPs increased the number receiving at least 1 shot by 9.5 percentage points.

© 2025 MJH Life Sciences

All rights reserved.